NovoCure Limited
US ˙ NasdaqGS ˙ JE00BYSS4X48

SecurityNVCR / NovoCure Limited
InstitutionFox Run Management, L.l.c.
Latest Disclosed Ownership42,989 shares
Latest Disclosed Value $ 445,366
Fox Run Management, L.l.c. reports 56.75% decrease in ownership of NVCR / NovoCure Limited

On May 12, 2026 - Fox Run Management, L.l.c. filed a 13F-HR form disclosing ownership of 42,989 shares of NovoCure Limited (US:NVCR) valued at $468,580 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 11, 2026 disclosing 99,405 shares of NovoCure Limited. This represents a change in shares of -56.75% during the quarter. The current value of the position is $694,272 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F NOVOCURE ORD SHS G6674U108 42,989 -56,416 -56.75 445 -65.37 0.0779
2026-02-11 2025-12-31 13F NOVOCURE ORD SHS G6674U108 99,405 52,587 112.32 1,285 112.75 0.1984
2025-11-12 2025-09-30 13F NOVOCURE ORD SHS G6674U108 46,818 26,530 130.77 605 67.31 0.0943
2025-08-06 2025-06-30 13F NOVOCURE ORD SHS G6674U108 20,288 20,288 361 0.0602
2025-02-11 2024-12-31 13F NOVOCURE ORD SHS G6674U108 0 -32,451 -100.00 0 -100.00
2024-11-12 2024-09-30 13F NOVOCURE ORD SHS G6674U108 32,451 32,451 507 0.1129
2024-08-13 2024-06-30 13F NOVOCURE ORD SHS G6674U108 0 -15,809 -100.00 0 -100.00
2024-05-13 2024-03-31 13F NOVOCURE ORD SHS G6674U108 15,809 -10,415 -39.72 247 -36.83 0.0533
2024-02-13 2023-12-31 13F NOVOCURE ORD SHS G6674U108 26,224 6,840 35.29 392 24.92 0.0999
2023-11-07 2023-09-30 13F NOVOCURE ORD SHS G6674U108 19,384 19,384 313 0.0927
2018-07-17 2018-06-30 13F NOVOCURE ORD SHS G6674U108 0 -10,597 -100.00 0 -100.00
2018-04-17 2018-03-31 13F NOVOCURE ORD SHS G6674U108 10,597 10,597 231 0.0560
2018-01-18 2017-12-31 13F NOVOCURE ORD SHS G6674U108 0 -23,200 -100.00 0 -100.00
2017-10-23 2017-09-30 13F NOVOCURE ORD SHS G6674U108 23,200 10,200 78.46 461 104.89 0.1306
2017-07-10 2017-06-30 13F NOVOCURE ORD SHS G6674U108 13,000 13,000 225 0.0778
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.